{"id":"ovulation-triggering-with-gnrh-a","_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Ovulation triggering with GnRH-a","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T05:32:15.644341+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T05:32:20.918371+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Ovulation triggering with GnRH-a","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T05:32:21.266091+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2370644/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T05:32:23.297226+00:00"}},"_dailymed":null,"_scrapedAt":"2026-03-27T23:59:18.015Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T05:32:24.883179+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT06804538","phase":"NA","title":"Interest of Sperm Insemination at 42 Hours Post hCG Compared to 36h in Intrauterine Insemination","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2025-09-09","conditions":"Infertility, Intrauterine Insemination (IUI)","enrollment":692},{"nctId":"NCT06150703","phase":"PHASE3","title":"Luteal Phase Support With GnRH Agonist After GnRH Agonist Triggering in IVF/ICSI Cycles","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-06-27","conditions":"In Vitro Fertilization, ICSI Intracytoplasmic Spermatozoid Injection","enrollment":652},{"nctId":"NCT02661932","phase":"PHASE4","title":"Fertility Preservation in Breast Cancer Patients","status":"COMPLETED","sponsor":"Erasme University Hospital","startDate":"2012-11","conditions":"Breast Neoplasms, Fertility","enrollment":65},{"nctId":"NCT04289805","phase":"PHASE4","title":"Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE)","status":"TERMINATED","sponsor":"Erasme University Hospital","startDate":"2019-02-25","conditions":"Breast Neoplasm Malignant Female","enrollment":96},{"nctId":"NCT02890082","phase":"PHASE2","title":"Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut Cancerologie de l'Ouest","startDate":"2014-02","conditions":"Breast Cancer","enrollment":102},{"nctId":"NCT04989348","phase":"NA","title":"Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol","status":"COMPLETED","sponsor":"Shanghai First Maternity and Infant Hospital","startDate":"2021-08-04","conditions":"IVF","enrollment":240},{"nctId":"NCT05521828","phase":"NA","title":"Luteal Phase Ovarian Stimulation With Follitropin Delta and Dydrogesterone","status":"UNKNOWN","sponsor":"CRG UZ Brussel","startDate":"2023-04-01","conditions":"Oocyte Donors, Oocyte Donation","enrollment":50},{"nctId":"NCT06199960","phase":"PHASE3","title":"Dual Ovarian Stimulation (Duostim) and Shanghai Protocols in Poor Ovarian Responders","status":"COMPLETED","sponsor":"Royan Institute","startDate":"2019-08-02","conditions":"Assisted Reproductive Techniques","enrollment":116},{"nctId":"NCT04724486","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI","status":"COMPLETED","sponsor":"Damascus University","startDate":"2020-08-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04724343","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2019-12-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04727684","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI","status":"COMPLETED","sponsor":"Damascus University","startDate":"2020-08-22","conditions":"In Vitro Fertilization, Infertility, Intracytoplasmic Sperm Injection","enrollment":50},{"nctId":"NCT04727671","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2019-12-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04992468","phase":"PHASE4","title":"Dual Trigger for Elective Fertility Preservation","status":"COMPLETED","sponsor":"Fundación Santiago Dexeus Font","startDate":"2021-10-05","conditions":"Infertility","enrollment":136},{"nctId":"NCT04586686","phase":"NA","title":"Combining Interventions of Fertility Preservation to Mitigate Fertility Loss After Breast Cancer","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2022-11-01","conditions":"Breast Cancer Female","enrollment":41},{"nctId":"NCT04108039","phase":"NA","title":"Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.","status":"COMPLETED","sponsor":"Fundacion Dexeus","startDate":"2019-09-25","conditions":"Infertility, IVF, Preimplantation Diagnosis","enrollment":44},{"nctId":"NCT04446845","phase":"PHASE4","title":"Double Stimulation Followed by a Fresh Embryo Transfer","status":"COMPLETED","sponsor":"Fundación Santiago Dexeus Font","startDate":"2020-10-30","conditions":"Infertility","enrollment":120},{"nctId":"NCT04071574","phase":"PHASE1, PHASE2","title":"Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility","status":"COMPLETED","sponsor":"Lebanese University","startDate":"2018-02-01","conditions":"Female Infertility, Female Infertility Due to Ovulatory Disorder, Premature Ovarian Failure","enrollment":200},{"nctId":"NCT05778331","phase":"","title":"The Difference Between POSEIDON Group 3 and Group 4 as Regards IVF","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2023-01-10","conditions":"Infertility, Female, IVF","enrollment":340},{"nctId":"NCT02703584","phase":"PHASE4","title":"Co Administration of GnRH Agonist and hCG for Final Oocyte Maturation","status":"COMPLETED","sponsor":"Mount Sinai Hospital, Canada","startDate":"2016-03","conditions":"Infertility","enrollment":276},{"nctId":"NCT04537078","phase":"PHASE3","title":"Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders","status":"COMPLETED","sponsor":"El Shatby University Hospital for Obstetrics and Gynecology","startDate":"2020-09-01","conditions":"Infertility, Female","enrollment":90},{"nctId":"NCT05143723","phase":"PHASE2","title":"Luteal Phase Support With Daily Administration of Gonadotropin-releasing Hormone Agonist Compared to Progesterone/Estradiol in IVF/ICSI Cycles With Ovulation Triggering With GnRH-a","status":"UNKNOWN","sponsor":"Kuban State Medical University","startDate":"2020-01-20","conditions":"Infertility","enrollment":102},{"nctId":"NCT05089344","phase":"NA","title":"Growth Hormone Pretreatment in Poseidon Type IV Undergoing ICSI Using Minimal Induction Protocol: A Randomized Controlled Trial","status":"UNKNOWN","sponsor":"Ain Shams Maternity Hospital","startDate":"2021-10-09","conditions":"Poor Response to Ovulation Induction Poseidon Type IV","enrollment":132},{"nctId":"NCT03877185","phase":"","title":"A New Revolutionary 3-Injection- Protocol in Infertile Women","status":"UNKNOWN","sponsor":"Assisting Nature","startDate":"2018-07-01","conditions":"Infertility, Female","enrollment":100},{"nctId":"NCT02715336","phase":"PHASE4","title":"Efficacy and Safety of Medication Used to Stimulate Ovulation","status":"UNKNOWN","sponsor":"Create Fertility Center","startDate":"2015-10","conditions":"IVF Cycle, Ovarian Stimulation, Egg Retrieval","enrollment":666},{"nctId":"NCT02821819","phase":"PHASE4","title":"Random-start Ovarian Stimulation in Egg-donors (ROSE)","status":"TERMINATED","sponsor":"Instituto Bernabeu","startDate":"2017-01-10","conditions":"Infertility","enrollment":15},{"nctId":"NCT02431689","phase":"NA","title":"Delayed Embryo Transfer in Poor Responders","status":"COMPLETED","sponsor":"Cairo University","startDate":"2015-04","conditions":"Infertility","enrollment":400},{"nctId":"NCT02381821","phase":"","title":"Endometrial Volume and Sub-endometrial Vascularity as Predictors of In-vitro Fertilization Success","status":"COMPLETED","sponsor":"Cairo University","startDate":"2016-01-01","conditions":"Reproductive Techniques, Assisted","enrollment":82},{"nctId":"NCT02208986","phase":"NA","title":"GnRHa Trigger in Asian Oocyte Donors- a Dose Finding Study","status":"COMPLETED","sponsor":"Vietnam National University","startDate":"2014-08","conditions":"Normal Oocyte Donors","enrollment":165},{"nctId":"NCT02827656","phase":"NA","title":"Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS","status":"UNKNOWN","sponsor":"Meir Medical Center","startDate":"2016-08","conditions":"Infertility","enrollment":50},{"nctId":"NCT02813239","phase":"","title":"Dual Triggering in Patients With a High Immature Oocyte Rate","status":"COMPLETED","sponsor":"IVI Madrid","startDate":"2014-11","conditions":"INFERTILITY","enrollment":81},{"nctId":"NCT02640976","phase":"EARLY_PHASE1","title":"Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program","status":"COMPLETED","sponsor":"Cairo University","startDate":"2013-06","conditions":"Infertility","enrollment":216},{"nctId":"NCT02070198","phase":"PHASE4","title":"Long Acting FSH Plus Antagonist Versus Daily FSH Plus Antagonist Versus Short Agonist Protocol in Poor Responders Undergoing IVF","status":"UNKNOWN","sponsor":"Bioroma","startDate":"2013-12","conditions":"Female Infertility, Poor Responder","enrollment":120},{"nctId":"NCT01210144","phase":"PHASE4","title":"EXpression PRofile Endometrium Samples Study","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2008-08","conditions":"In Vitro Fertilization","enrollment":27},{"nctId":"NCT00627406","phase":"PHASE4","title":"Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles","status":"COMPLETED","sponsor":"Regionshospitalet Viborg, Skive","startDate":"2009-01","conditions":"OHSS (Ovarian Hyperstimulation)","enrollment":384},{"nctId":"NCT01732068","phase":"PHASE2","title":"Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist Protocol","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2012-07","conditions":"Infertility, Poor Ovarian Response","enrollment":51},{"nctId":"NCT00954811","phase":"PHASE4","title":"Luteal Supplementation With Rec-LH After GnRH-agonist Triggering in In Vitro (IVF)","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2005-09","conditions":"Pregnancy, Pregnancy Loss","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL2370644"},"_approvalHistory":[],"publicationCount":76,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Ovulation triggering with GnRH-a","genericName":"Ovulation triggering with GnRH-a","companyName":"Fundación Santiago Dexeus Font","companyId":"fundaci-n-santiago-dexeus-font","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T05:32:24.883179+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}